IDEAS home Printed from https://ideas.repec.org/a/epw/biomed/v1y2022i4id2020.html

Assessment of HER2/neu among Female with Invasive Ductal Breast Carcinoma, Using Manual Tissue Microarray Technology in Khartoum State, Sudan

Author

Listed:
  • Rania M. Sidahmed
  • Abdalraheem A. Babiker
  • Elhadi A. Ahmed
  • Alaa E. Abbas

Abstract

The human epidermal growth factor receptor-2 (HER2), which is expressed in large amount in 20%-30% of breast cancer patients, is associated with disease recurrences, shortened disease survival, and bad prognosis. The aim of this study is to evaluate the expression of (Her2/neu) receptor as a diagnostic and prognostic marker in Invasive Ductal Breast cancer in Sudanese female patients. The study was performed on 35 archival paraffin blocks previously diagnosed as invasive ductal breast cancer (IDC), then a second diagnosis was done using IHC staining (Her2/neu). The obtained information is arranged in a standard master sheet, then analyzed using a statistical package for social science (SPSS) version 20 computer program. The age 30-45years was the most frequent age group 48.6% (17/35), followed by 46-60 years 40% (14/35). The majority of samples were grade III 74.3% (26/35) and the samples of grade II were 25.7% (9/35). the majority of TMA results were positive for Her2/neu receptor 65.7% (23/35) and the negative results were 34.3% (12/35) the majority of TMA score were (+) 31.4% (11/35), followed by (++) 17.2% (6/35), then (+++) 11.4% (4/35), then (++++) 5.7% (2/35), and the negative result were, 34.3% (12/35). There was a significant relation between H&E diagnosis with TMA result for Her2/ neu diagnosis that the P-value (0.0002). There was an insignificance relation between H&E diagnosis of grades with TMA results for Her2/ neu diagnosis that the P-value (0.08). In conclusion, HER2 is over-expressed in 65.7% of the patient while internationally it is over-expressed in 15-30%. This provides valuable prognostic and predictive implications in order to choose the suitable treatment for the patients.

Suggested Citation

  • Rania M. Sidahmed & Abdalraheem A. Babiker & Elhadi A. Ahmed & Alaa E. Abbas, 2022. "Assessment of HER2/neu among Female with Invasive Ductal Breast Carcinoma, Using Manual Tissue Microarray Technology in Khartoum State, Sudan," European Journal of Biomedical Research, European Open Science, vol. 1(4), pages 10-13, August.
    • Handle: RePEc:epw:biomed:v:1:y:2022:i:4:id:2020
    DOI: 10.24018/ejbiomed.2022.1.4.20
    as

    Download full text from publisher

    File URL: https://eu-opensci.org/index.php/ejbiomed/article/view/2020
    File Function: Abstract page
    Download Restriction: no
    File URL: https://eu-opensci.org/index.php/ejbiomed/article/download/2020/470
    File Function: Full text
    Download Restriction: no
    File URL: https://libkey.io/10.24018/ejbiomed.2022.1.4.20?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Abubaker M. Hamad & Rania M. Sidahmed & Nada S. Haj Mukhtar & Helal G. Alanazi & Hussain G. Ahmed, 2022. "Status and Association of BRCA1 and BRCA2 Mutation with Clinicopathological Features in Sudanese Patients with Breast Cancer," European Journal of Biology and Biotechnology, European Open Science, vol. 3(1), pages 68-74, January.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.

      More about this item

      Keywords

      ;
      ;
      ;
      ;

      JEL classification:

      Statistics

      Access and download statistics

      Corrections

      All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:epw:biomed:v:1:y:2022:i:4:id:2020. See general information about how to correct material in RePEc.

      If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

      If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

      If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

      For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Support Team (email available below). General contact details of provider: https://eu-opensci.org/index.php/ejbiomed .

      Please note that corrections may take a couple of weeks to filter through the various RePEc services.

      IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.